Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Arcot Systems, Inc. - Arcot Digital Signature Solution Certified Compliant with SAFE-BioPharma Digital Standard™
Biopharmaceuticals - GPhA Statement on the Introduction of the Bipartisan Senate Biogenerics Consensus Bill: 'Promoting Innovation and Access to Life-Saving Medicine Act'
Cancer - Ezetimibe and Ezetimibe/Simvastatin Combo Pose No Increased Cancer Risk, Study Shows
Clinical Trial Research - Coast IRB Tells Congressional Committee Sting Operation Was Illegal, Unnecessarily Harmful
Food Poisoning - GAO Study Links Duty Circumvention with Evasion of Food Safety Laws
Advaxis, Incorporated - Advaxis Updates Phase I Trial Survival Data: 23% of Patients Still Surviving after 2+ Years
Allos Therapeutics, Inc. - Allos Therapeutics Submits New Drug Application for Pralatrexate for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
Alnara Pharmaceuticals - Alnara Pharmaceuticals Licenses Worldwide Rights to Liprotamase from Cystic Fibrosis Foundation
Anesthesia - Research findings from C.F. Wang et al update understanding of anesthesia
Antares Pharma, Inc. - Antares Pharma Reports Fourth Quarter and Year End 2008 Financial and Operating Results
Anthrax - Study results from E.J. Duncan and colleagues update understanding of anthrax
Atrial Fibrillation - Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, the Largest Atrial Fibrillation Outcomes Trial To Date
Autism - Curemark Receives Investigational New Drug Clearance for CM-AT for Autism
BioMedReports.com - FDA Calendar, Unbiased Reporting on Emerging Biotech Sector Now Available at BioMedReports.com
Bioterrorism - Researchers from Department of Agriculture publish findings in biochemistry
Bioterrorism - Studies from University of Pittsburgh, Medical Department have provided new information about bioterrorism
Bone Fractures - NovaLign(TM) Orthopaedics, Inc. Announces its First 510(K) Clearance From the FDA for New Intramedullary Fixation System
Bone Research - Hip Resurfacing Championed as a Bone-Preserving Alternative to Total Hip Replacement
Camstar Systems, Inc. - New Research Results Show Impact of Quality Systems in Life Sciences
Cancer - Findings from University of Southern Denmark, National Institute of Public Health advance knowledge in cancer
Cancer - IROs Help Decide Medically on Approved Uses of Off-Label Drugs for Cancer
Cancer - Statement of the American Cancer Society Cancer Action Network, American Heart Association, American Lung Association and the Campaign for Tobacco-Free Kids
Cancer Vaccines - ImQuest Presentations at Keystone Symposium Focus on Advancements in Their Therapeutic and Microbicide Development Programs
Cancer Vaccines - Research from W.W. Wang and co-researchers in the area of cancer vaccines published
CardiacAssist Inc. - CardiacAssist Introduces Longer Cannula Set for Its TandemHeart® System
Ortho-McNeil-Janssen Pharmaceuticals Inc. - FDA Advisory Committee Finds Favorable Risk-Benefit Profile for Oral Anticoagulant Rivaroxaban for Prophylaxis of Deep Vein Thrombosis and Pulmonary Embolism After Hip or Knee Replacement Surgery
Ovarian Cancer - Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer
Pharmaceuticals - Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
Prostate Cancer - Columbus Children's Hospital publishes research in prostate cancer
Public Health - Crossflo Provides Data Sharing for Montana Health Information Exchange
RAND Corporation - Study finds program has improved health agencies' preparedness for bioterror and disease outbreaks
Regulatory Actions - Research from J.P. Myers and co-researchers in the area of regulatory actions described
Research and Markets - Analysis of AERS Data on Anti-Diabetics Provides a Detailed Analysis on the Adverse Events Reported in the FDA AERS Database
Research and Markets - The Bactericidal and Oligodynamic Action of Silver and Copper in Hygiene, Medicine and Water Treatment
Rexahn Pharmaceuticals, Inc. - Rexahn Pharmaceuticals, Inc. RNN Initiates Phase II Pancreatic Cancer Clinical Trial
Spectrum Pharmaceuticals, Inc. - Spectrum Pharmaceuticals Announces That FDA Has Accepted FUSILEV™ sNDA for Colorectal Cancer Indication